0001209191-12-014711.txt : 20120301 0001209191-12-014711.hdr.sgml : 20120301 20120301193209 ACCESSION NUMBER: 0001209191-12-014711 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120228 FILED AS OF DATE: 20120301 DATE AS OF CHANGE: 20120301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moffat Duncan H CENTRAL INDEX KEY: 0001433586 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33966 FILM NUMBER: 12659719 MAIL ADDRESS: STREET 1: C/O MAKO SURGICAL CORP. STREET 2: 2555 DAVIE ROAD CITY: FORT LAUDERDALE STATE: FL ZIP: 33317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAKO Surgical Corp. CENTRAL INDEX KEY: 0001411861 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 201901148 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2555 DAVIE ROAD CITY: FT. LAUDERDALE STATE: FL ZIP: 33317 BUSINESS PHONE: 954-927-2044 MAIL ADDRESS: STREET 1: 2555 DAVIE ROAD CITY: FT. LAUDERDALE STATE: FL ZIP: 33317 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-02-28 0 0001411861 MAKO Surgical Corp. MAKO 0001433586 Moffat Duncan H C/O MAKO SURGICAL CORP. 2555 DAVIE ROAD FT. LAUDERDALE FL 33317 0 1 0 0 SVP of Operations Common Stock 2012-02-28 4 M 0 6300 7.94 A 24207 D Common Stock 2012-02-28 4 S 0 6300 40.004 D 17907 D Common Stock 2012-02-29 4 M 0 12800 7.94 A 30707 D Common Stock 2012-02-29 4 S 0 12800 40.024 D 17907 D Employee Stock Option (Right to Buy) 7.94 2012-02-28 4 M 0 6300 0.00 D 2018-04-28 Common Stock 6300 68488 D Employee Stock Option (Right to Buy) 7.94 2012-02-29 4 M 0 12800 0.00 D 2018-04-28 Common Stock 12800 55688 D The exercise and sales reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2011. The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.05 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. The price in column 4 is a weighted average price per share. The prices actually paid ranged from $40.00 to $40.12 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Vests and becomes exercisable ratably quarterly over four years commencing on the grant date. /s/ Menashe R. Frank, attorney in fact 2012-03-01